People with diabetes who are U.S. citizens or permanent residents can apply for a free lifetime America the Beautiful Pass, which offers access to over 2,000 parks,...
Type 1 Diabetes News
Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels.
71 readers recommended
Medtronic unveils Simplera, the latest CGM approved in Europe for people with diabetes ages two and older. A sleek, disposable device, Simplera rivals the Dexcom G7 and...
50 readers recommended
Researchers find automated insulin delivery (AID) systems, the MiniMed 780G and Omnipod 5, showed significant improvement in time in range for everyday users. This real-...
104 readers recommended
Ongoing hostilities and violence across the world leave people with diabetes in crisis and without access to essential resources. What can be done to help?
52 readers recommended
Explore the profound issue of diabetes stigma and steps we can take to combat it. From the Language Matters movement to personal stories and global pledges, discover how...
37 readers recommended
This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.
102 readers recommended
Determining ideal carbohydrate intake for those with type 1 diabetes remains complex. Two studies at EASD 2023 highlight the benefits of a plant-based diet and...
41 readers recommended
Rising type 2 diabetes rates demand new approaches. The 2022 ADA/EASD Consensus Report emphasizes person-centered care, medications for glycemic control and weight loss...
52 readers recommended
People with type 1 diabetes face higher kidney risks, yet treatments approved for type 2 aren't FDA approved for them due to clinical trial gaps. The EASD 2023 panel...
232 readers recommended
A third patient with type 1 diabetes becomes insulin-independent after VX-880 stem cell treatment. Presented at the 2023 EASD conference, Vertex's early-phase trial...
56 readers recommended
Despite advancements in diabetes treatment, emergency department visits among adults with diabetes surged 21% from 2014-2018. The 2023 EASD Conference unveils updated...
50 readers recommended
Hypo-RESOLVE collaborates internationally to advance hypoglycemia understanding in diabetes. Evolving from a once-understudied concern, its Hypo-METRICS app now captures...
38 readers recommended
Experts addressed rising rates of cardiovascular disease in children with diabetes at EASD 2023, emphasizing prevention and finding new biomarkers for early...
38 readers recommended
At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...
94 readers recommended
The newest study of once-weekly insulins showed that insulin icodec led to similar reductions in A1C and similar time in range compared to once-daily Tresiba (degludec).
59 readers recommended
Diabetic foot ulcers are a common and costly complication for people with diabetes. ON101 is a promising new topical treatment anticipated for FDA approval in the coming...
139 readers recommended
Living with type 1 diabetes for over two decades, the author shares a harrowing tale of an unexpected diabetic complication threatening her vision. Discover her journey...
79 readers recommended
The FDA is cautioning people that the diabetes medication Ozempic – commonly prescribed off-label for weight loss – may be linked to a rare but severe side effect.
83 readers recommended
Our team is on the way to Hamburg, Germany, to cover the latest in diabetes medications, research, and technology at the European Association for the Study of Diabetes...
28 readers recommended
Here are our top stories from September 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings, and more.